Patent: 4,866,036
✉ Email this page to a colleague
Summary for Patent: 4,866,036
Title: | Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose compositions and methods of use in aids-immunocompromised human hosts |
Abstract: | Disclosed are specific dipeptidyl 5-0, 6-0-Acyl-2-amino-2-deoxy-D-glucofuranoses, which, either alone, or in combination with an anti-AIDS drug, e.g. azidothymidine, provide protection in human individuals whose resistance to infection has been specifically suppressed by an AIDS-related (HIV) virus, as well as help to suppress the AIDS-related infection itself. |
Inventor(s): | Durette; Philippe L. (New Providence, NJ) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 07/105,057 |
Patent Claims: | see list of patent claims |
Details for Patent 4,866,036
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | June 04, 2004 | 4,866,036 | 2039-03-29 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | June 13, 2008 | 4,866,036 | 2039-03-29 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |